Vanda Pharmaceuticals (VNDA) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.71% |
| Dec 31, 2025 | 6.98% |
| Sep 30, 2025 | -107.36% |
| Jun 30, 2025 | 53.99% |
| Mar 31, 2025 | -1,724.27% |
| Dec 31, 2024 | 87.54% |
| Sep 30, 2024 | -110.46% |
| Jun 30, 2024 | -191.53% |
| Mar 31, 2024 | 302.81% |
| Dec 31, 2023 | -82.05% |
| Sep 30, 2023 | 84.49% |
| Jun 30, 2023 | -141.57% |
| Mar 31, 2023 | 237.75% |
| Dec 31, 2022 | -26.65% |
| Sep 30, 2022 | 125.80% |
| Jun 30, 2022 | 40.51% |
| Mar 31, 2022 | -84.79% |
| Dec 31, 2021 | 183.14% |
| Sep 30, 2021 | -50.59% |
| Jun 30, 2021 | 106.86% |
| Mar 31, 2021 | -52.37% |
| Dec 31, 2020 | 105.91% |
| Sep 30, 2020 | -60.95% |
| Jun 30, 2020 | 2,746.75% |
| Mar 31, 2020 | -109.26% |
| Dec 31, 2019 | 63.24% |
| Sep 30, 2019 | -70.76% |
| Jun 30, 2019 | 112.74% |
| Mar 31, 2019 | -36.82% |
| Dec 31, 2018 | 75.56% |
| Sep 30, 2018 | 98.00% |
| Jun 30, 2018 | 168.07% |
| Mar 31, 2018 | -52.74% |
| Dec 31, 2017 | 59.87% |
| Sep 30, 2017 | 195.93% |
| Jun 30, 2017 | 57.81% |
| Mar 31, 2017 | -352.83% |
| Dec 31, 2016 | -195.33% |
| Sep 30, 2016 | 138.04% |
| Jun 30, 2016 | 33.41% |
| Mar 31, 2016 | -1,276.12% |
| Dec 31, 2015 | 92.66% |
| Sep 30, 2015 | -140.09% |
| Jun 30, 2015 | 117.84% |
| Mar 31, 2015 | 141.50% |
| Dec 31, 2014 | -76.15% |
| Sep 30, 2014 | 79.27% |
| Jun 30, 2014 | -53.38% |
| Mar 31, 2014 | -96.69% |
| Dec 31, 2013 | -18.32% |
| Sep 30, 2013 | -27.70% |
| Jun 30, 2013 | 11.86% |
| Mar 31, 2013 | 34.11% |
| Dec 31, 2012 | -36.26% |
| Sep 30, 2012 | 16.78% |
| Jun 30, 2012 | -40.55% |
| Mar 31, 2012 | 29.68% |
| Dec 31, 2011 | -72.34% |
| Sep 30, 2011 | -27.60% |
| Jun 30, 2011 | -72.15% |
| Mar 31, 2011 | 35.95% |
| Dec 31, 2010 | -0.43% |